BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33821851)

  • 1. Outcomes of Jehovah's Witnesses with hematological malignancies treated without transfusions - single center experience.
    Drozd-Sokołowska JE; Waszczuk-Gajda A; Dwilewicz-Trojaczek J; Walesiak A; Krzyżanowska M; Paluszewska M; Wieczorek J; Jędrzejczak WW
    Folia Med Cracov; 2020; 60(4):53-64. PubMed ID: 33821851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report.
    Tenenbaum T; Hasan C; Kramm CM; Janssen G; Laws HJ; Wessalowski R; Bode U; Göbel U
    Onkologie; 2004 Apr; 27(2):131-7. PubMed ID: 15138344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
    Ford PA; Grant SJ; Mick R; Keck G
    J Clin Oncol; 2015 May; 33(15):1674-9. PubMed ID: 25870085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There Sufficient Evidence Justifying Limited Access of Jehovah's Witness Patients to Kidney Transplantation?
    Carvalho Fiel D; Nunes Ficher K; Bernardi Taddeo J; Linhares Silva K; Rosso Felipe C; Aguiar W; Daniel Braz Cardone J; Foresto RD; Tedesco-Silva H; Medina-Pestana J
    Transplantation; 2021 Jan; 105(1):249-254. PubMed ID: 33350627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience.
    Mazza P; Prudenzano A; Amurri B; Palazzo G; Pisapia G; Stani L; Pricolo G
    Bone Marrow Transplant; 2003 Aug; 32(4):433-6. PubMed ID: 12900781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis.
    Wilop S; Osieka R
    Hematology; 2018 Jul; 23(6):324-329. PubMed ID: 29212421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
    Laszlo D; Agazzi A; Goldhirsch A; Cinieri S; Bertolini F; Rabascio C; Pruneri G; Calabrese L; Cocquio A; Martinelli G
    Eur J Haematol; 2004 Apr; 72(4):264-7. PubMed ID: 15089764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute leukaemia in adult Jehovah's Witnesses.
    El Chaer F; Ballen KK
    Br J Haematol; 2020 Sep; 190(5):696-707. PubMed ID: 31693175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study.
    Nanni G; Vitolo M; Imberti JF; Girolami D; Bonini N; Valenti AC; Cimato P; Boriani G
    Intern Emerg Med; 2023 Jan; 18(1):151-162. PubMed ID: 36401716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mortality after high-risk surgery in Jehovah's Witness patients].
    Habler O; Thörner M; Schmidt C; Hofmann P; Döbert U; Höhler M; Klingler S; Moog S; Oehme A; Schäufele M; Wege C; Voß B
    Anaesthesist; 2019 Jul; 68(7):444-455. PubMed ID: 31236704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To transfuse or not to transfuse? Jehovah's Witnesses and postoperative hemorrhage in pediatric otolaryngology.
    Redmann AJ; Schopper M; Antommaria AHM; Ragsdale J; de Alarcón A; Rutter MJ; Hart CK; Myer CM
    Int J Pediatr Otorhinolaryngol; 2018 Dec; 115():188-192. PubMed ID: 30368384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jehovah's Witness Patients: Interventions for Successful Stem Cell Transplantation Without Blood Product Transfusions for Hematologic Malignancies.
    Park A; Rome S; Gantioque R
    Clin J Oncol Nurs; 2019 Aug; 23(4):364-369. PubMed ID: 31322623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Bloodless" Neurosurgery Among Jehovah's Witnesses: A Comparison with Matched Concurrent Controls.
    Hardesty DA; Doerfler S; Sandhu S; Whitmore RG; Ford P; Rushton S; LeRoux PD
    World Neurosurg; 2017 Jan; 97():132-139. PubMed ID: 27641256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open Heart Surgery in Jehovah's Witnesses: A Propensity Score Analysis.
    Müller H; Ratschiller T; Schimetta W; Meier J; Gombotz H; Zierer A
    Ann Thorac Surg; 2020 Feb; 109(2):526-533. PubMed ID: 31408643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodless tandem autologous transplant in Jehovah's Witness patients.
    Khan R; Mott SL; Schultz A; Jethava YS; Tricot G
    Bone Marrow Transplant; 2018 Nov; 53(11):1428-1433. PubMed ID: 29795417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
    Zhou L; Mohsen A; Khan MA; Guthrie T
    J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reports of 12 Cases of Stanford Type A Acute Aortic Dissection Emergent Surgery for Jehovah's Witnesses patients].
    Abe K; Kondoh H; Ishida M; Kajiyama T; Matsue H; Satoh H
    Kyobu Geka; 2020 Mar; 73(3):178-182. PubMed ID: 32393698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma.
    Chang Lee R; Sukumaran S; Koczwara B; Woodman R; Kichenadasse G; Roy A; Vatandoust S; Karapetis C
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1148. PubMed ID: 32721085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution.
    Costanzo D; Bindi M; Ghinolfi D; Esposito M; Corradi F; Forfori F; De Simone P; De Gasperi A; Biancofiore G
    BMC Anesthesiol; 2020 Jan; 20(1):31. PubMed ID: 32000668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.